Skip to content
PubMed This is a summary of 23 peer-reviewed journal articles Updated
Endocrinology · Hypocalcemia

How Do Hypoparathyroidism, PHP, and ADH Differ in Tests?

At a Glance

Low calcium can result from too little parathyroid hormone, resistance to its signal, or an overactive calcium sensor. Blood, urine, and sometimes genetic tests help distinguish hypoparathyroidism, pseudohypoparathyroidism, and autosomal-dominant hypocalcemia and guide treatment that protects the kidneys.

When you are diagnosed with low blood calcium (hypocalcemia), determining the exact cause is essential. While many causes of low calcium share symptoms like tingling, muscle cramps, fatigue, and brain fog, they stem from different underlying problems. Hypoparathyroidism due to inadequate PTH production occurs when your body simply does not make enough parathyroid hormone (PTH) [1]. Pseudohypoparathyroidism (PHP) happens when your body produces PTH, but your organs resist its signals [2]. Autosomal-dominant hypocalcemia (ADH) is a genetic condition caused by a gain-of-function variant where your body’s calcium sensors are overly sensitive [3]. Because symptoms alone cannot distinguish these conditions, figuring out the exact cause relies on blood tests, urine tests, and sometimes genetic evaluation [4][5].

Urgent Safety Warning: Seek emergency medical care immediately for severe or rapidly worsening muscle spasms (tetany), seizures, fainting, trouble breathing or swallowing, marked confusion, chest pain, palpitations, or an irregular heartbeat. Never attempt to correct suspected low calcium with large, unsupervised doses of calcium or vitamin D.

Confirming the Low Calcium First

Before exploring rare genetic conditions, your doctor will confirm true hypocalcemia using an albumin-adjusted calcium or ionized calcium test, since low albumin can make total calcium look falsely low [6][7]. They will also check your magnesium, phosphate, kidney function, and vitamin D levels [4].

This initial workup is crucial because common acquired problems can mimic rare conditions. For instance, severe vitamin D deficiency or kidney disease can alter your calcium and PTH levels [4]. Most importantly, low magnesium (hypomagnesemia) can directly suppress your parathyroid glands from releasing PTH, causing low calcium that often resolves once the magnesium is corrected [4].

How PTH Normally Works

Parathyroid hormone (PTH) is the primary messenger that regulates calcium. It normally helps maintain blood calcium in three ways: it tells your bones to release stored calcium, tells your kidneys to conserve calcium rather than excreting it into urine, and helps your kidneys produce active vitamin D [1]. Active vitamin D then increases the amount of calcium your intestines absorb from the food you eat [8].

Hypoparathyroidism Due to Inadequate PTH Production

This is what most people mean by the general term “hypoparathyroidism.” It occurs when your parathyroid glands are damaged (most commonly from neck surgery) or fail to produce enough PTH [9][4].

Because there is not enough PTH to keep calcium levels balanced, blood tests typically show:

  • Low blood calcium [6]
  • High blood phosphate (hyperphosphatemia) [1]
  • Low or inappropriately normal PTH levels [6]

Pseudohypoparathyroidism (PHP): Resistance to the Signal

In pseudohypoparathyroidism (PHP)—increasingly referred to by specialists as an inactivating PTH/PTHrP signaling disorder (iPPSD)—the parathyroid glands produce PTH normally. However, a genetic anomaly prevents the kidneys and bones from receiving or responding to the signal, a phenomenon known as end-organ resistance [10][11].

The laboratory profile for PHP includes:

  • Low blood calcium and high blood phosphate [2].
  • Elevated PTH levels (compensatory), as the body tries to send a louder signal that the kidneys are ignoring [10][12].

Some forms of PHP (often tied to the GNAS gene) are accompanied by physical characteristics collectively known as Albright hereditary osteodystrophy (AHO) [13]. AHO can include short stature, a stocky build, early-onset obesity, and shortened bones in the hands and feet [14]. However, the presence and severity of these features vary widely, and their absence does not rule out PHP [14].

Autosomal-Dominant Hypocalcemia (ADH): A Faulty Sensor

Autosomal-dominant hypocalcemia (ADH) is a genetic disorder affecting the calcium-sensing receptor (CaSR) or its signaling pathways [3][15]. Think of the CaSR as your body’s calcium thermostat. In ADH, a gain-of-function variant sets the thermostat incorrectly; it becomes overly sensitive and detects low or normal calcium levels as being too high, instructing the body to shut down PTH production and dump calcium into the urine [3].

Routine blood tests for ADH mimic inadequate PTH production, presenting with low calcium, high phosphate, and low or normal PTH [3][4]. However, there are distinct clues:

  • High urine calcium (hypercalciuria): Patients with ADH type 1 (ADH1) often spill excessive amounts of calcium into their urine [3][16].
  • Low magnesium: ADH1 frequently causes low blood magnesium levels [3][17].
  • Genetics: ADH1 is caused by CASR gene variants, while ADH type 2 (ADH2) is caused by GNA11 variants [18][15]. “Autosomal dominant” means an affected parent has a 50% chance of passing the variant to each child, though symptoms and severity can vary widely even within the same family [15][19].

Understanding Urine Calcium and Treatment Safety

Urgent kidney complications, such as kidney stones or calcium deposits (nephrocalcinosis), are a major concern when managing these conditions [20][15]. In conditions with low PTH or ADH, treatment with calcium supplements and active vitamin D is often necessary to safely raise blood calcium, but it can accidentally drive urinary calcium levels even higher [20][15].

Important: Do not stop, reduce, or change your prescribed calcium or active vitamin D therapies without your clinician’s direct guidance.

Urine calcium is heavily influenced by your kidney function, hydration, dietary sodium, and treatments like active vitamin D or thiazide diuretics [4][21]. Because treatment can unmask or worsen high urine calcium, a single urine calcium test cannot definitively prove or exclude ADH [15][21]. Your doctor will interpret these tests in context to individualize your treatment targets and protect your kidneys [4].

Typical Laboratory Patterns

(Note: These are typical patterns, not strict diagnostic rules. They must be interpreted by a doctor in the context of your kidney function, medications, and vitamin D status.)

Condition Blood Calcium Phosphate PTH Magnesium Typical Urine Calcium
Inadequate PTH Production Low High Low / Normal Normal Normal or Elevated
PHP (PTH Resistance) Low High High Normal Low or Normal
ADH1 (Faulty Sensor) Low High Low / Normal Low High (Variable)
ADH2 (Faulty Sensor) Low High Low / Normal Normal Normal

When to Consider Genetic Testing and Specialists

Not everyone with low calcium needs a genetic panel, especially if there is a clear acquired cause like a recent neck surgery [5]. However, your doctor may refer you to an endocrinologist or clinical geneticist if your low calcium is unexplained, developed at a young age, or you have a family history of low calcium, seizures, kidney stones, or AHO features [5][17].

Genetic testing requires expert guidance; for instance, some forms of PHP require specialized methylation testing because routine DNA sequencing might miss the underlying defect [22][10]. A confirmed genetic diagnosis can inform your kidney monitoring strategy, guide your long-term treatment safely, and help identify at-risk family members [23][19].

(Note: The bracketed codes in this article, like [19], are identifiers for the specific medical research papers that support these facts.)

Common questions in this guide

How are hypoparathyroidism, pseudohypoparathyroidism, and autosomal-dominant hypocalcemia different?
With hypoparathyroidism, the parathyroid glands do not make enough PTH. With pseudohypoparathyroidism, PTH is present but the kidneys and bones resist its signal. With autosomal-dominant hypocalcemia, an overactive calcium sensor suppresses PTH and can increase calcium loss in urine.
What blood test patterns suggest each cause of low calcium?
Inadequate PTH production and autosomal-dominant hypocalcemia usually show low calcium, high phosphate, and a PTH level that is low or not high enough for the low calcium. Pseudohypoparathyroidism usually shows low calcium, high phosphate, and high PTH. ADH type 1 may also cause low magnesium and high urine calcium, although results vary.
How do doctors confirm that calcium is truly low?
Doctors may use albumin-adjusted calcium or ionized calcium because a low albumin level can make total calcium appear low. They also commonly check PTH, magnesium, phosphate, vitamin D, and kidney function. These tests help separate acquired causes, such as vitamin D deficiency or low magnesium, from PTH-related or genetic disorders.
Can urine calcium prove that I have autosomal-dominant hypocalcemia?
No. High urine calcium can be a clue to ADH type 1, while pseudohypoparathyroidism often has low or normal urine calcium, but urine results are affected by kidney function, hydration, sodium intake, and medicines. Doctors interpret urine calcium alongside blood tests and treatment history.
When should genetic testing be considered for unexplained low calcium?
Genetic evaluation may be considered when low calcium is unexplained, began at a young age, or occurs with a family history of low calcium, seizures, kidney stones, or physical features associated with Albright hereditary osteodystrophy. Testing may include CASR or GNA11 analysis for autosomal-dominant hypocalcemia, while some pseudohypoparathyroidism cases need specialized methylation testing. A genetics professional can help choose and interpret the test.
Can treatment for low calcium affect the kidneys?
Calcium supplements and active vitamin D can raise blood calcium but may also increase calcium in the urine, which can contribute to kidney stones or nephrocalcinosis. Your clinician may monitor urine calcium and kidney function and may use other measures, such as a thiazide diuretic, when appropriate. Do not stop or change prescribed treatment without medical guidance.
Which low-calcium symptoms require emergency care?
Seek emergency medical care for severe or rapidly worsening muscle spasms, seizures, fainting, trouble breathing or swallowing, marked confusion, chest pain, palpitations, or an irregular heartbeat. Do not try to correct suspected low calcium with large, unsupervised doses of calcium or vitamin D.

Get notified when new evidence is published on Hypoparathyroidism.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (23)
  1. 1

    Hypoparathyroidism.

    Bilezikian JP

    The Journal of clinical endocrinology and metabolism 2020; (105(6)) doi:10.1210/clinem/dgaa113.

    PMID: 32322899
  2. 2

    Pseudohypoparathyroidism.

    Linglart A, Levine MA, Jüppner H

    Endocrinology and metabolism clinics of North America 2018; (47(4)):865-888 doi:10.1016/j.ecl.2018.07.011.

    PMID: 30390819
  3. 3

    Autosomal Dominant Hypocalcemia (Hypoparathyroidism) Types 1 and 2.

    Roszko KL, Bi RD, Mannstadt M

    Frontiers in physiology 2016; (7()):458 doi:10.3389/fphys.2016.00458.

    PMID: 27803672
  4. 4

    Best practice recommendations for the diagnosis and management of hypoparathyroidism.

    Khan AA, Ali DS, Bilezikian JP, et al.

    Metabolism: clinical and experimental 2025; (171()):156335 doi:10.1016/j.metabol.2025.156335.

    PMID: 40581321
  5. 5

    Non-Classical Presentations of Rare Hereditary Hypoparathyroidism: A Case Series of CASR, GNA11 and GATA3 Mutations.

    Bibik E, Meirambek K, Salimkhanov R, et al.

    Clinical endocrinology 2026; (105(1)):116-121 doi:10.1111/cen.70141.

    PMID: 41952051
  6. 6

    Hypoparathyroidism: Genetics and Diagnosis.

    Mannstadt M, Cianferotti L, Gafni RI, et al.

    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2022; (37(12)):2615-2629 doi:10.1002/jbmr.4667.

    PMID: 36375809
  7. 7

    Real-world management of hypoparathyroidism: the impact of endocrinology specialist follow-up on biochemical and clinical outcomes - a retrospective cohort study.

    Doğan Çakır S, Adaş M

    BMC endocrine disorders 2026; (26(1)).

    PMID: 42426679
  8. 8

    Therapy with PTH 1-34 or calcitriol and calcium in diverse etiologies of hypoparathyroidism over 27 years at a single tertiary care center.

    Winer KK, Ye S, Ferré EMN, et al.

    Bone 2021; (149()):115977 doi:10.1016/j.bone.2021.115977.

    PMID: 33932619
  9. 9

    Standards of care for hypoparathyroidism in adults: a Canadian and International Consensus.

    Khan AA, Koch CA, Van Uum S, et al.

    European journal of endocrinology 2019; (180(3)):P1-P22.

    PMID: 30540559
  10. 10

    Pseudohypoparathyroidism type 1B (PHP1B), a rare disorder encountered in adolescence.

    Vlachopapadopoulou EA, Anagnostou E, Dikaiakou E, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2020; (33(11)):1475-1479.

    PMID: 33027051
  11. 11

    Identification of novel pathogenic variants and features in patients with pseudohypoparathyroidism and acrodysostosis, subtypes of the newly classified inactivating PTH/PTHrP signaling disorders.

    Truelove A, Mulay A, Prapa M, et al.

    American journal of medical genetics. Part A 2019; (179(7)):1330-1337 doi:10.1002/ajmg.a.61163.

    PMID: 31041856
  12. 12

    Variable Bone Phenotypes in Patients with Pseudohypoparathyroidism.

    Wang Y, Lu C, Chen X

    Current osteoporosis reports 2023; (21(3)):311-321 doi:10.1007/s11914-023-00787-6.

    PMID: 37014531
  13. 13

    Pseudohypoparathyroidism: complex disease variants with unfortunate names.

    Jüppner H

    Journal of molecular endocrinology 2024; (72(1)).

    PMID: 37965945
  14. 14

    [Implication in Paediatrics of the First International Consensus Statement for the Diagnosis and management of pseudohypoparathyroidism and related disorders].

    Martos-Moreno GÁ, Lecumberri B, Pérez de Nanclares G

    Anales de pediatria 2019; (90(2)):125.e1-125.e12 doi:10.1016/j.anpedi.2018.11.014.

    PMID: 30591400
  15. 15

    Autosomal Dominant Hypocalcemia Type 1: A Systematic Review.

    Roszko KL, Stapleton Smith LM, Sridhar AV, et al.

    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2022; (37(10)):1926-1935 doi:10.1002/jbmr.4659.

    PMID: 35879818
  16. 16

    Recombinant human parathyroid hormone (1-84) is effective in CASR-associated hypoparathyroidism.

    Hawkes CP, Shulman DI, Levine MA

    European journal of endocrinology 2020; (183(6)):K13-K21.

    PMID: 33112267
  17. 17

    Renal and systemic complications in autosomal dominant hypocalcemia type 1: a case series from North East England.

    Manoharan D, Wong EKS, Mabillard H, et al.

    Journal of the Endocrine Society 2026; (10(10)):bvag205 doi:10.1210/jendso/bvag205.

    PMID: 42775144
  18. 18

    Identification of a G-Protein Subunit-α11 Gain-of-Function Mutation, Val340Met, in a Family With Autosomal Dominant Hypocalcemia Type 2 (ADH2).

    Piret SE, Gorvin CM, Pagnamenta AT, et al.

    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2016; (31(6)):1207-14 doi:10.1002/jbmr.2797.

    PMID: 26818911
  19. 19

    Prenatal features and neonatal management of severe hyperparathyroidism caused by the heterozygous inactivating calcium-sensing receptor variant, Arg185Gln: A case report and review of the literature.

    Aubert-Mucca M, Dubucs C, Groussolles M, et al.

    Bone reports 2021; (15()):101097 doi:10.1016/j.bonr.2021.101097.

    PMID: 34169121
  20. 20

    Differential parathyroid and kidney Ca2+-sensing receptor activation in autosomal dominant hypocalcemia 1.

    van Megen WH, Tan RSG, Alexander RT, Dimke H

    EBioMedicine 2022; (78()):103947 doi:10.1016/j.ebiom.2022.103947.

    PMID: 35313217
  21. 21

    Autosomal Dominant Hypocalcemia With Atypical Urine Findings Accompanied by Novel CaSR Gene Mutation and VitD Deficiency.

    Tsuji T, Hiroyuki A, Uraki S, et al.

    Journal of the Endocrine Society 2021; (5(3)):bvaa190 doi:10.1210/jendso/bvaa190.

    PMID: 33506158
  22. 22

    Adult-onset pseudohypoparathyroidism type 1B diagnosed by methylation analysis: A case report and diagnostic considerations.

    Choi HS, Kim HK, Suh SH, et al.

    Medicine 2026; (105(11)):e47943 doi:10.1097/MD.0000000000047943.

    PMID: 41824862
  23. 23

    Genetics of hereditary forms of primary hyperparathyroidism.

    English KA, Lines KE, Thakker RV

    Hormones (Athens, Greece) 2024; (23(1)):3-14 doi:10.1007/s42000-023-00508-9.

    PMID: 38038882

This page is for informational purposes only and does not constitute medical advice. An endocrinologist or other qualified clinician should interpret your calcium, PTH, urine, and genetic test results and guide treatment.